Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Haluska

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Advances in Enzyme Regulation|October 8, 1998
A role for the amino terminus of human topoisomerase IP Haluska, E H Rubin
Current Opinion in Investigational Drugs (London, England : 2000)|January 31, 2002
Receptor tyrosine kinase inhibitorsP Haluska, A A Adjei
Hematology/Oncology Clinics of North America|March 18, 1999
Topoisomerase-I inhibitors in gynecologic tumorsP Haluska, E Rubin, C F Verschraegen
Expert Opinion on Investigational Drugs|January 5, 2002
Novel pharmacological agents in clinical development for solid tumoursG K Dy, P Haluska, A A Adjei
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|June 18, 2002
[Massive localized lymphedema in an extremely obese patient]J Vána, K Adamicová, P Haluska, et al.
European Journal of Cancer (Oxford, England : 1990)|August 15, 2002
Farnesyl transferase inhibitors as anticancer agentsP Haluska, G K Dy, A A Adjei
Ceskoslovenska Patologie|September 28, 2002
[Massive localized lymphedema: a reactive lesion simulating liposarcoma (case report]K Adamicová, J Vána, J Celec, et al.
Nucleic Acids Research|May 30, 1998
Interaction between the N-terminus of human topoisomerase I and SV40 large T antigenP Haluska, A Saleem, T K Edwards, et al.
Biochimica Et Biophysica Acta|March 19, 2015
Prioritizing therapeutic targets using patient-derived xenograft modelsK A Lodhia, A M Hadley, P Haluska, et al.
Nucleic Acids Research|June 3, 1999
Interaction between human topoisomerase I and a novel RING finger/arginine-serine proteinP Haluska, A Saleem, Z Rasheed, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Advances in Enzyme Regulation|October 8, 1998
A role for the amino terminus of human topoisomerase IP Haluska, E H Rubin
Current Opinion in Investigational Drugs (London, England : 2000)|January 31, 2002
Receptor tyrosine kinase inhibitorsP Haluska, A A Adjei
Hematology/Oncology Clinics of North America|March 18, 1999
Topoisomerase-I inhibitors in gynecologic tumorsP Haluska, E Rubin, C F Verschraegen
Expert Opinion on Investigational Drugs|January 5, 2002
Novel pharmacological agents in clinical development for solid tumoursG K Dy, P Haluska, A A Adjei
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|June 18, 2002
[Massive localized lymphedema in an extremely obese patient]J Vána, K Adamicová, P Haluska, et al.
European Journal of Cancer (Oxford, England : 1990)|August 15, 2002
Farnesyl transferase inhibitors as anticancer agentsP Haluska, G K Dy, A A Adjei
Ceskoslovenska Patologie|September 28, 2002
[Massive localized lymphedema: a reactive lesion simulating liposarcoma (case report]K Adamicová, J Vána, J Celec, et al.
Nucleic Acids Research|May 30, 1998
Interaction between the N-terminus of human topoisomerase I and SV40 large T antigenP Haluska, A Saleem, T K Edwards, et al.
Biochimica Et Biophysica Acta|March 19, 2015
Prioritizing therapeutic targets using patient-derived xenograft modelsK A Lodhia, A M Hadley, P Haluska, et al.
Nucleic Acids Research|June 3, 1999
Interaction between human topoisomerase I and a novel RING finger/arginine-serine proteinP Haluska, A Saleem, Z Rasheed, et al.
Pageof 2